Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,104 hedge funds and large institutions have $68.4B invested in Allergan plc in 2017 Q1 according to their latest regulatory filings, with 135 funds opening new positions, 401 increasing their positions, 453 reducing their positions, and 105 closing their positions.
29% more first-time investments, than exits
New positions opened: 135 | Existing positions closed: 105
7% more capital invested
Capital invested by funds: $64B → $68.4B (+$4.41B)
1% more funds holding
Funds holding: 1,091 → 1,104 (+13)
11% less repeat investments, than reductions
Existing positions increased: 401 | Existing positions reduced: 453
13% less funds holding in top 10
Funds holding in top 10: 89 → 77 (-12)
22% less call options, than puts
Call options by funds: $2.64B | Put options by funds: $3.38B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.61B |
| 2 |
VAM
Veritas Asset Management
London,
United Kingdom
|
+$742M |
| 3 |
Jennison Associates
New York
|
+$379M |
| 4 |
Goldman Sachs
New York
|
+$302M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$216M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
-$574M |
| 2 |
State Street
Boston,
Massachusetts
|
-$447M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$393M |
| 4 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
-$308M |
| 5 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$286M |
AGN Hedge Fund Activity: Q1 2017 in Review
1,104 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2017, worth a combined $68.4B — up 6.9% from $64B a quarter earlier.
Buyers outnumbered sellers: 135 funds opened new AGN positions and 105 closed out — a net gain of 30 holders — while 401 added to existing stakes and 453 trimmed.
The largest buyer was BlackRock, adding an estimated $4.61B. The largest seller was Elliott Management, exiting entirely with an estimated $574M sold.
- 1,104 institutional investors held Allergan plc (AGN) as of Q1 2017, up from 1,091 in Q4 2016.
- Funds reported $68.4B of Allergan plc stock for Q1 2017, up 6.9% quarter-over-quarter.
- 135 funds opened new Allergan plc positions in Q1 2017 and 105 closed out, a net change of +30 holders.
- The largest Allergan plc buyer in Q1 2017 was BlackRock, an estimated $4.61B added.
- The largest Allergan plc seller in Q1 2017 was Elliott Management, an estimated $574M sold.
Based on aggregated 13F filings for Q1 2017.